|
Jul. 2, 07: Accident Raises Safety Concerns About Chinese Tires (Topic: Abilify)
Wall Street Journal reports that more than 450,000 Chinese-made tires may lack an important safety feature. read more »
Jul. 2, 07: Accident Raises Safety Concerns About Chinese Tires (Topic: Abilify)
Wall Street Journal reports that more than 450,000 Chinese-made tires may lack an important safety feature read more »
Apr. 23, 07: FDA Aware of Dangers to Food (Topic: Contaminated Foods)
Washington Post Reports FDA Knew of Contamination Problems read more »
Apr. 23, 07: FDA Aware of Dangers to Food (Topic: Abilify)
Washington Post Reports FDA Knew of Contamination Problems read more »
Mar. 12, 07: Vioxx jury awards $20M to Idaho couple (Topic: Vioxx)
Merck & Co.'s painkiller Vioxx contributed to an Idaho postal worker's heart attack, a jury in Atlantic City ruled Monday, reversing the verdict in the man's first trial and awarding him and his wife... read more »
Mar. 12, 07: Jury blames Vioxx for man's heart attack, awards $20M (Topic: Vioxx)
Merck's former painkiller Vioxx contributed to the heart attack of an Idaho postal worker, a state jury in Atlantic City ruled Monday. The jury awarded Frederick "Mike" Humeston and his wife $20 milli... read more »
Feb. 13, 07: FDA Curbs Use of Ketek (Topic: Ketek)
Federal regulators Monday narrowed the approved uses of the controversial antibiotic Ketek, and said they will add new safety warnings for the drug. read more »
Feb. 12, 07: FDA limits use of risky Sanofi antibiotic Ketek (Topic: Ketek)
Sanofi-Aventis SA's antibiotic Ketek should no longer be used to treat sinusitis and bronchitis, U.S. officials warned on Monday, saying the controversial drug was too risky to treat those diseases. read more »
Feb. 12, 07: FDA tightens labeling, indications for Ketek (Topic: Ketek)
The Food and Drug Administration on Monday announced labeling changes for the antibiotic Ketek, stripping it of two previously approved indications and adding a black-box warning, the agency's stronge... read more »
Feb. 12, 07: Sanofi's Ketek Is Restricted by U.S. Before Hearing (Update6) (Topic: Ketek)
Feb. 12 (Bloomberg) -- Sanofi-Aventis SA was banned from selling its Ketek antibiotic in the U.S. for bronchitis and sinusitis a day before lawmakers debate the safety of the drug. read more »
|
|
| | |
